<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">sibmed</journal-id><journal-title-group><journal-title xml:lang="ru">Сибирский научный медицинский журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Сибирский научный медицинский журнал</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2410-2512</issn><issn pub-type="epub">2410-2520</issn><publisher><publisher-name>ИЦиГ СО РАН</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.18699/SSMJ20240618</article-id><article-id custom-type="elpub" pub-id-type="custom">sibmed-1838</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>МЕДИКО-БИОЛОГИЧЕСКИЕ НАУКИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>BIOMEDICINE</subject></subj-group></article-categories><title-group><article-title>Уровень апоптоза в клетках неокортекса и гиппокампа белых крыс после легкой черепно-мозговой травмы при введении глипролина</article-title><trans-title-group xml:lang="en"><trans-title>The level of apoptosis in the cells of the neocortex and hippocampus of white rats after mild traumatic brain injury with the introduction of glyproline</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9337-2801</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Флейшман</surname><given-names>М. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Fleishman</surname><given-names>M. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Флейшман Марина Юрьевна - д.м.н.</p><p>680000, Хабаровск, ул. Муравьева-Амурского, 35</p></bio><bio xml:lang="en"><p>Marina Yu. Fleishman - doctor of medical sciences.</p><p>680000, Khabarovsk, Murav’yeva-Amurskogo st., 35</p></bio><email xlink:type="simple">marfl@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сальников</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Salnikov</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Сальников Антон Александрович.</p><p>680000, Хабаровск, ул. Муравьева-Амурского, 35</p></bio><bio xml:lang="en"><p>Anton A. Salnikov.</p><p>680000, Khabarovsk, Murav’yeva-Amurskogo st., 35</p></bio><email xlink:type="simple">anton231100@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Колесникова</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Kolesnikova</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Колесникова Анна Александровна.</p><p>680000, Хабаровск, ул. Муравьева-Амурского, 35</p></bio><bio xml:lang="en"><p>Anna A. Kolesnikova.</p><p>680000, Khabarovsk, Murav’yeva-Amurskogo st., 35</p></bio><email xlink:type="simple">anna-kostina-88@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5698-3665</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Малофей</surname><given-names>Ю. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Malofey</surname><given-names>Yu. B.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Малофей Юлия Борисовна - к.б.н.</p><p>680000, Хабаровск, ул. Муравьева-Амурского, 35</p></bio><bio xml:lang="en"><p>Yliya B. Malofey - candidate of biological sciences.</p><p>680000, Khabarovsk, Murav’yeva-Amurskogo st., 35</p></bio><email xlink:type="simple">malofey2009@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Дальневосточный государственный медицинский университет Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Far Eastern State Medical University of Minzdrav of Russia</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>07</day><month>01</month><year>2025</year></pub-date><volume>44</volume><issue>6</issue><fpage>179</fpage><lpage>185</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Флейшман М.Ю., Сальников А.А., Колесникова А.А., Малофей Ю.Б., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Флейшман М.Ю., Сальников А.А., Колесникова А.А., Малофей Ю.Б.</copyright-holder><copyright-holder xml:lang="en">Fleishman M.Y., Salnikov A.A., Kolesnikova A.A., Malofey Y.B.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://sibmed.elpub.ru/jour/article/view/1838">https://sibmed.elpub.ru/jour/article/view/1838</self-uri><abstract><p>Глипролины обладают широким спектром фармакологических эффектов, в том числе антиоксидантной активностью. Это может быть использовано при коррекции функциональных и морфологических нарушений головного мозга после черепно-мозговой травмы (ЧМТ) за счет ингибирования вторичных повреждений, профилактика которых является главным способом улучшения исходов ЧМТ. Цель исследования – изучить уровень апоптоза в клетках собственно теменной доли (СТД) и поля CA1 гиппокампа половозрелых самцов крыс Вистар после легкой ЧМТ и курсового введения глипролина RPGP (Arg-Pro-Gly-Pro). Материал и методы. В эксперименте использовали ткани мозга крыс (n = 38). Легкую ЧМТ моделировали путем свободного падения груза. После травмы животные получали внутрибрюшинно пептид RPGP в дозе 0,1 мг/кг, растворенный в 0,9%-м растворе NaCl, или 0,9%-й раствор NaCl. Уровень апоптоза в тканях мозга оценивали по экспрессии антигена p53 методом иммуногистохимии. Результаты. На 22-й день после ЧМТ повышается количество клеток глии, вступивших в апоптоз во II слое СТД головного мозга крыс Вистар. У животных, подвергнутых моделированной ЧМТ и 21 день получавших внутрибрюшинно RPGP дозе 0,1 мг/кг, уровень апоптоза не повышался. Заключение. Установлено, что после курсового введения RPGP на фоне ЧМТ уровень апоптоза в клетках нейроглии снижается.</p></abstract><trans-abstract xml:lang="en"><p>Glyprolines have a wide range of pharmacological effects, including antioxidant effects. This can be used to correct functional and morphological disorders of the brain after traumatic brain injury (TBI) by inhibiting secondary damage, the prevention of which is the main way to improve TBI outcomes. The aim of the study was to investigate the level of apoptosis in the cells of the proper parietal lobe (PPL) and the CA1 field of the hippocampus of mature male Wistar rats after mild TBI and a course of glyproline RPGP (Arg-Pro-Gly-Pro). Material and methods. Rat brain tissues (n = 38) were used in the experiment. Mild TBI was modeled by free fall of a load. After the injury, the animals received intraperitoneal RPGP peptide at a dose of 0.1 mg/kg, dissolved in 0.9% NaCl solution or NaCl solution. The level of apoptosis in brain tissues was assessed by the expression of p53 antigen using immunohistochemistry. Results. On the 22st day after TBI, the number of glial cells that entered into apoptosis in layer II of the proper parietal lobe (PPL) of the Wistar rat brain increases. In animals subjected to simulated TBI and receiving RPGP intraperitoneally at a dose of 0.1 mg/kg for 21 days, the level of apoptosis did not increase. Conclusion. It was found that after a course of RPGP administration against the background of TBI, the level of apoptosis in neuroglial cells decreases.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>глипролины</kwd><kwd>регуляторные пептиды</kwd><kwd>апоптоз</kwd><kwd>неокортекс</kwd><kwd>черепно-мозговая травма</kwd></kwd-group><kwd-group xml:lang="en"><kwd>glyprolines</kwd><kwd>regulatory peptides</kwd><kwd>apoptosis</kwd><kwd>neocortex</kwd><kwd>traumatic brain injury</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Работа выполнена в рамках государственного задания № 124022900081-9. Авторы выражают благодарность руководителю лаборатории молекулярной фармакологии пептидов ФГБУ НИЦ «Курчатовский институт» академику РАН Н.Ф. Мясоедову.</funding-statement><funding-statement xml:lang="en">The work was carried out within the framework of state assignment No. 124022900081-9. The authors express their gratitude to the head of the laboratory of molecular pharmacology of peptides of the Federal State Budgetary Institution National Research Center “Kurchatov Institute”, academician of the Russian Academy of Sciences N.F. Myasoedov.</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Хавинсон В.Х. Лекарственные пептидные препараты: прошлое, настоящее, будущее. Клин. мед. 2020;98(3):65–177. doi: 10.30629/0023-2149-2020-98-3-165-177</mixed-citation><mixed-citation xml:lang="en">Khavinson V.Kh. Peptide medicines: past, present, future. Klinicheskaya meditsina = Clinical Medicine. 2020;98(3):165–177. [In Russian]. doi: 10.30629/0023-2149-2020-98-3-165-177</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Жуйкова С.Е. Физиологические и клинические эффекты синтетического аналога АКТГ4-10 семакса и его механизмы действия. Интегратив. физиол. 2022;3(2):204–220. doi: 10.33910/2687-1270-2022-3-2-204-220</mixed-citation><mixed-citation xml:lang="en">Zhuikova S.E. Physiological effects of Semax, a synthetic analogue of ACTH4–10: Experience and prospects for applications. Integrativnaya fiziologiya = Integrative Physiology. 2022;3(2):204–220. [In Russian]. doi: 10.33910/2687-1270-2022-3-2-204-220</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Shi Y., Liu L., Yu Y., Long Y., Zheng H. Acidic amino acids: A new-type of enzyme mimics with application to biosensing and evaluating of antioxidant behavior. Spectrochim. Acta. A. Mol. Biomol. Spectrosc. 2018;(201):367–375. doi: 10.1016/j.saa.2018.05.024</mixed-citation><mixed-citation xml:lang="en">Shi Y., Liu L., Yu Y., Long Y., Zheng H. Acidic amino acids: A new-type of enzyme mimics with application to biosensing and evaluating of antioxidant behavior. Spectrochim. Acta. A. Mol. Biomol. Spectrosc. 2018;(201):367–375. doi: 10.1016/j.saa.2018.05.024</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Цибизова А.А., Сергалиева М.У., Самотруева М.А. Оценка антиоксидантной активности глипролинов в условиях экспериментального гипертиреоза. Ученые записки Крымского федерального университета имени В.И. Вернадского. Биология. Химия. 2023;9(2):219–228. doi: 10.29039/2413-1725-2023-9-2-219-228</mixed-citation><mixed-citation xml:lang="en">Tsibizova A.A., Sergalieva M.U., Samotrueva M.A.Assessment of the antioxidant activity of glyprolins in experimental hyperthyroidism. Uchenye zapiski Krymskogo federal’nogo universiteta imeni Vladimira Ivanovicha Vernadskogo. Biologiya. Khimiya = Scientific Notes of V.I. Vernadsky Crimean Federal University. Biology. Chemistry. 2023;9(2):219–228. [In Russian]. doi: 10.29039/2413-1725-2023-9-2-219-228</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Закирова Э.Г., Зайнуллина Л.Ф., Вахитова Ю.В. Нейропротекторные свойства пептида Arg-Pro-Gly-Pro. Инновации в науке. 2017;(7-1):4–7.</mixed-citation><mixed-citation xml:lang="en">Zakirova E.G., Zainullina L.F., Vakhitova Yu.V. Neuroprotective properties of the peptide Arg-Pro-Gly-Pro. Innovatsii v nauke. = Innovation in Science. 2017;7(1):4–7. [In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Кулинич Т.М., Иванов А.В., Захаренко М.В., Джикия Е.Л., Шишкин А.М., Боженко В.К. Интернализуемые пептиды (сell-penetrating peptides, CPPs) и возможности их терапевтического применения. Вестн. Рос. науч. центра рентгенорадиол. 2020;(4):106–126.</mixed-citation><mixed-citation xml:lang="en">Kulinich T.M., Ivanov A.V., Zakharenko M.V., Dzhikiya E.L., Shishkin A.M., Bozhenko V.K. Cell-penetrating peptides (CPPs) and their therapeutic application. Vestnik Rossiyskogo nauchnogo tsentra rentgenoradiologii = Bulletin of the Russian Scientific Center of Roentgenology. 2020;(4):106–126. [In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Сазонова Е.Н., Самарина Е.Ю., Ильиных А.В., Сазонов О.А. Использование метода кислотных эритрограмм для выявления мембранотропного эффекта биологически активных пептидов. Дальневост. мед. ж. 2020;(4):64–68. doi: 10.35177/1994-5191-2020-4-65-69</mixed-citation><mixed-citation xml:lang="en">Sazonova E.N., Samarina E.Yu., Ilinykh A.V., Sazonov O.A. Implementation of the method of acidic erythrograms to reveal the membranotropic effect of biologically active peptides. Dal’nevostochnyy meditsinskiy zhurnal = Far East Medical Journal. 2020;(4):64–68. [In Russian]. doi: 10.35177/1994-5191-2020-4-65-69</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">de Martini L.B., Sulmona C., Brambilla L., Rossi D. Cell-penetrating peptides as valuable tools for nose-to-brain delivery of biological drugs. Cells. 2023;12(12):1643. doi: 10.3390/cells12121643</mixed-citation><mixed-citation xml:lang="en">de Martini L.B., Sulmona C., Brambilla L., Rossi D. Cell-penetrating peptides as valuable tools for nose-to-brain delivery of biological drugs. Cells. 2023;12(12):1643. doi: 10.3390/cells12121643</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Григорьева М.Е., Ляпина Л.А. Роль пептидов глипролинового ряда в регуляции системы гемостаза при стрессогенных воздействиях. Успехи соврем. биол. 2020;140(1):19–25. doi: 10.31857/S0042132420010020</mixed-citation><mixed-citation xml:lang="en">Grigoryeva M.E., Lyapina L.A. Role of glyproline peptides in the regulationof haemostasis system under stress conditions. Uspekhi sovremennoy biologii = Biology Bulletin Reviews. 2020;140(1):19–25. [In Russian]. doi: 10.31857/S0042132420010020</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Белошицкий В.В. Принципы моделирования черепно-мозговой травмы в эксперименте. Укр. нейрохірург. ж. 2008(4):9–15.</mixed-citation><mixed-citation xml:lang="en">Biloshitskiy V.V. The principles of experimental traumatic brain injury modelling. Ukrayinsʹkiy neyrokhirurhichniy zhurnal = Ukrainian Neurosurgical Journal. 2008(4):9–15. [In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Барвина А.Р. Современные правила применения параметрических и непараметрических критериев в статистическом анализе медико-биологических данных. Мед. альм. 2021;(1):64–73.</mixed-citation><mixed-citation xml:lang="en">Barvina A.R. Modern rules for the use of parametric and nonparametric tools in the statistical analysis of biomedical data. Meditsinskiy al’manakh = Medical Almanac. 2021;(1):64–73. [In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Семененко А.И. Оценка терапевтического эффекта 0,9 % раствора NaCl по показателям церебральной гемодинамики при ишемии-реперфузии головного мозга крыс. Ж. Гродненск. гос. мед. ун-та. 2014;(3):49–52.</mixed-citation><mixed-citation xml:lang="en">Semenenko A.I. Assessment of the therapeutic effect of 0.9% NaCl on indicators of cerebral hemodynamics in ischemia-reperfusion of rat brain. Zhurnal Grodnenskogo gosudarstvennogo meditsinskogo universiteta = Journal of the Grodno State Medical University. 2014;(3):49–52. [In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Флейшман М.Ю., Толстeнок И.В., Иннокентьев А.А. Влияние пептида «Cеланк» на уровень окислительного стресса в головном мозге и тонкой кишке белых крыс на модели черепно-мозговой травмы. Сиб. науч. мед. ж. 2019;39(2):46–51. doi: 10.15372/SSMJ20190205</mixed-citation><mixed-citation xml:lang="en">Fleishman M.Yu., Tolstenok I.V., Innokentyev A.A. Effects of peptide Selank on oxidative stress in the brain and thin intestine of white rats on experimental model of traumatic brain injury. Sibirskij nauchnyj medicinskij zhurnal = Siberian Scientific Medical Journal. 2019;39(2):46–51. [In Russian]. doi: 10.15372/SSMJ20190205</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Соловьева А.Г., Кузнецова В.Л., Перетягин С.П., Диденко Н.В., Дударь А.И. Роль оксида азота в процессах свободнорадикального окисления. Вестн. Рос. воен.-мед. акад. 2016;(1):228–233.</mixed-citation><mixed-citation xml:lang="en">Solovieva A.G., Kuznetsova V.L., Peretyagin S.P., Didenko N.V., Dudar A.I. Role of nitric oxide in processes of free radical oxidation. Vestnik Rossiyskoy voyenno-meditsinskoy akademii = Bulletin of the Russian Military Medical Academy. 2016;(1):228–233. [In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Suschek C.V., Schnorrn O., Hemmrich K., Aust O., Klotz L.O., Sies H., Kolb-Bachofen V. Critical role of L-arginine in endothelial cell survival during oxidative stress. Circulation. 2003;107(20):2607–2614. doi: 10.1161/01.CIR.0000066909.13953.F1</mixed-citation><mixed-citation xml:lang="en">Suschek C.V., Schnorrn O., Hemmrich K., Aust O., Klotz L.O., Sies H., Kolb-Bachofen V. Critical role of L-arginine in endothelial cell survival during oxidative stress. Circulation. 2003;107(20):2607–2614. doi: 10.1161/01.CIR.0000066909.13953.F1</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Grovola M.R., Jinich A., Paleologos N., Arroyo E.J., Browne K.D., Swanson R.L., Duda J.E., Cullen D.K. Persistence of hyper-ramified microglia in porcine cortical gray matter after mild traumatic brain injury. Biomedicines. 2023;11(7):1960. doi: 10.3390/biomedicines11071960</mixed-citation><mixed-citation xml:lang="en">Grovola M.R., Jinich A., Paleologos N., Arroyo E.J., Browne K.D., Swanson R.L., Duda J.E., Cullen D.K. Persistence of hyper-ramified microglia in porcine cortical gray matter after mild traumatic brain injury. Biomedicines. 2023;11(7):1960. doi: 10.3390/biomedicines11071960</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">George K.K., Heithoff B.P., Shandra O., Robel S. Mild traumatic brain injury/concussion initiates an atypical astrocyte response caused by blood-brain barrier dysfunction. J. Neurotrauma. 2022;39(1-2):211–226. doi: 10.1089/neu.2021.0204</mixed-citation><mixed-citation xml:lang="en">George K.K., Heithoff B.P., Shandra O., Robel S. Mild traumatic brain injury/concussion initiates an atypical astrocyte response caused by blood-brain barrier dysfunction. J. Neurotrauma. 2022;39(1-2):211–226. doi: 10.1089/neu.2021.0204</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Zhao Q., Zhang J., Li H., Li H, Xie F. Models of traumatic brain injury-highlights and drawbacks. Front. Neurol. 2023;(14):1151660. doi: 10.3389/fneur.2023.1151660</mixed-citation><mixed-citation xml:lang="en">Zhao Q., Zhang J., Li H., Li H, Xie F. Models of traumatic brain injury-highlights and drawbacks. Front. Neurol. 2023;(14):1151660. doi: 10.3389/fneur.2023.1151660</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
